Chris Robertson

3.2k total citations · 1 hit paper
17 papers, 2.4k citations indexed

About

Chris Robertson is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Chris Robertson has authored 17 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cancer Research. Recurrent topics in Chris Robertson's work include Estrogen and related hormone effects (11 papers), Breast Cancer Treatment Studies (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Chris Robertson is often cited by papers focused on Estrogen and related hormone effects (11 papers), Breast Cancer Treatment Studies (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Chris Robertson collaborates with scholars based in Italy, United Kingdom and Norway. Chris Robertson's co-authors include Viviana Galimberti, Alberto Luini, Stefano Zurrida, Mattia Intra, Paolo Veronesi, Giuseppe Renne, Roberto Gennari, Giuseppe Viale, Concetta De Cicco and Umberto Veronesi and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Chris Robertson

17 papers receiving 2.4k citations

Hit Papers

A Randomized Comparison of Sentinel-Node Biopsy with Rout... 2003 2026 2010 2018 2003 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Robertson Italy 13 1.7k 1.2k 941 849 359 17 2.4k
Claire Holloway Canada 25 1.3k 0.8× 839 0.7× 783 0.8× 1.0k 1.2× 124 0.3× 87 2.6k
A G Nash United Kingdom 19 868 0.5× 527 0.4× 444 0.5× 842 1.0× 474 1.3× 45 1.9k
W Jack United Kingdom 26 1.3k 0.8× 572 0.5× 598 0.6× 1.2k 1.4× 305 0.8× 65 2.4k
Csaba Gajdos United States 26 834 0.5× 485 0.4× 702 0.7× 1.2k 1.4× 262 0.7× 72 2.3k
H.T. Mouridsen Denmark 22 1.3k 0.8× 438 0.4× 261 0.3× 1.4k 1.6× 634 1.8× 49 2.5k
J A McKinna United Kingdom 26 959 0.6× 704 0.6× 346 0.4× 913 1.1× 875 2.4× 51 2.5k
Gabriele Martelli Italy 19 807 0.5× 539 0.5× 416 0.4× 501 0.6× 109 0.3× 44 1.2k
Theresa McHugh United Kingdom 3 2.9k 1.8× 1.4k 1.2× 954 1.0× 1.4k 1.6× 276 0.8× 3 4.0k
Joan Houghton United Kingdom 11 965 0.6× 383 0.3× 574 0.6× 1.0k 1.2× 494 1.4× 14 1.8k
S Legault-Poisson United States 10 644 0.4× 304 0.3× 727 0.8× 1.5k 1.8× 299 0.8× 13 2.0k

Countries citing papers authored by Chris Robertson

Since Specialization
Citations

This map shows the geographic impact of Chris Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Robertson more than expected).

Fields of papers citing papers by Chris Robertson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Robertson. The network helps show where Chris Robertson may publish in the future.

Co-authorship network of co-authors of Chris Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Robertson. A scholar is included among the top collaborators of Chris Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Robertson. Chris Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
DeCensi, Andrea, Chris Robertson, Aliana Guerrieri‐Gonzaga, et al.. (2009). Randomized Double-Blind 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women. Journal of Clinical Oncology. 27(23). 3749–3756. 87 indexed citations
2.
Sills, Graeme J., John Paul Leach, Martin J. Brodie, et al.. (2009). Response to drug treatment in newly diagnosed epilepsy: A pilot study of 1H NMR- and MS-based metabonomic analysis. Epilepsy Research. 88(2-3). 189–195. 15 indexed citations
3.
Johansson, Harriet, Massimiliano Cazzaniga, Bernardo Bonanni, et al.. (2006). Effects of low dose tamoxifen on circulating levels of hormones, C-telopeptide and HER2 extracellular domain in women with primary breast cancer. Cancer Research. 66. 753–753. 2 indexed citations
4.
Gonçalves, Frederico Bastos, et al.. (2005). 813: Phase III Study Intermittent Monotherapy versus Continuous Combined Androgen Deprivation an International Cooperative Study. The Journal of Urology. 173(4S). 220–220. 4 indexed citations
5.
Guerrieri‐Gonzaga, Aliana, Chris Robertson, Bernardo Bonanni, et al.. (2005). Preliminary Results on Safety and Activity of a Randomized, Double-Blind, 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in Premenopausal Women. Journal of Clinical Oncology. 24(1). 129–135. 32 indexed citations
6.
Gennari, Roberto, Giuseppe Curigliano, Nicole Rotmensz, et al.. (2004). Breast carcinoma in elderly women. Cancer. 101(6). 1302–1310. 161 indexed citations
7.
Veronesi, Umberto, Giovanni Paganelli, Giuseppe Viale, et al.. (2003). A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer. New England Journal of Medicine. 349(6). 546–553. 1609 indexed citations breakdown →
8.
Bono, Aldo, et al.. (2002). Phase III study of intermittent MAB versus continuous MAB international cooperative study. European Urology Supplements. 1(1). 135–135. 7 indexed citations
9.
DeCensi, Andrea, U. Omodei, Chris Robertson, et al.. (2002). Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women. Circulation. 106(10). 1224–1228. 100 indexed citations
10.
Biffi, Roberto, Filippo de Braud, Franco Orsi, et al.. (2001). A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. 92(5). 1204–1212. 107 indexed citations
11.
Johansson, Harriet, Sara Gandini, Aliana Guerrieri‐Gonzaga, et al.. (2001). Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women. Breast Cancer Research and Treatment. 69(1). 21–27. 33 indexed citations
12.
Guerrieri‐Gonzaga, Aliana, Laura Baglietto, Harriet Johansson, et al.. (2001). Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial.. PubMed. 10(9). 967–70. 24 indexed citations
13.
Zurrida, Stefano, Viviana Galimberti, Enrico Orvieto, et al.. (2000). Radioguided Sentinel Node Biopsy to Avoid Axillary Dissection in Breast Cancer. Annals of Surgical Oncology. 7(1). 28–31. 43 indexed citations
14.
DeCensi, Andrea, Aliana Guerrieri‐Gonzaga, Rosalba Torrisi, et al.. (2000). Chemoprevention of breast cancer: The Italian experience. Journal of Cellular Biochemistry. 77(S34). 84–96. 24 indexed citations
15.
Bonanni, Bernardo, Aliana Guerrieri‐Gonzaga, Nicole Rotmensz, et al.. (2000). Hormonal Therapy and Chemoprevention. The Breast Journal. 6(5). 317–323. 4 indexed citations
16.
DeCensi, Andrea, Sara Gandini, Aliana Guerrieri‐Gonzaga, et al.. (1999). Effect of Blood Tamoxifen Concentrations on Surrogate Biomarkers in a Trial of Dose Reduction in Healthy Women. Journal of Clinical Oncology. 17(9). 2633–2633. 72 indexed citations
17.
DeCensi, Andrea, Bernardo Bonanni, Aliana Guerrieri‐Gonzaga, et al.. (1998). Biologic Activity of Tamoxifen at Low Doses in Healthy Women. JNCI Journal of the National Cancer Institute. 90(19). 1461–1467. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026